INmune Bio Inc (INMB) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $1.34
• Market Cap: $36.95M
• EPS: $-2.08
• 52-Week High: $8.94
• 52-Week Low: $1.21

Market Sentiment

INmune Bio Inc currently has a Bullish sentiment score of 0.39.

About INmune Bio Inc

INmune Bio Inc., based in La Jolla, California, is a pioneering clinical-stage immunotherapy company focusing on reprogramming the innate immune system to tackle challenging diseases such as cancer, Alzheimer's disease, and nonalcoholic steatohepatitis. With a promising pipeline of innovative therapies, INmune Bio is strategically positioned to lead advancements in immunotherapy, leveraging the body’s natural defenses to achieve better clinical outcomes. The company’s unwavering commitment to...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for INmune Bio Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does INMB pay dividends?

INmune Bio Inc (INMB) does not currently pay a regular dividend.

What is INMB's market cap?

INmune Bio Inc (INMB) has a market capitalization of $36.95M with a current stock price of $1.34.